The report offers an overview of the Idiopathic Pulmonary Fibrosis with the help of application segments and geographical regions (United States, Europe, China, Japan, Southeast Asia, India, Central & South America, ROW) that govern the market currently.
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by scarring (fibrosis) of the lungs. The fibrosis causes the lung tissue to thicken and stiffen over time, making it difficult to breathe. While the cause of IPF is unknown, it usually affects older adults and has no cure. In this article, we will discuss what is known about IPF, including causes, risk factors, diagnosis, treatment options, and research efforts.
